The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Combined estrogen and progestin contraceptives

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 4 SUPPL., 2011, Pages

  Shulman, Lee P ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

androgenic effects; contraceptive side effects; menstrual cycle control; venous thromboembolism

Indexed keywords

DROSPIRENONE PLUS ESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; GESTAGEN;

ARTICLE; BEHAVIOR DISORDER; BIRTH CONTROL; BREAST TENDERNESS; CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DYSMENORRHEA; EMOTIONAL DISORDER; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEALTH HAZARD; HORMONAL CONTRACEPTION; HUMAN; LUNG EMBOLISM; MENSTRUAL IRREGULARITY; MENSTRUATION; MORBIDITY; MORTALITY; NAUSEA; NURSE; OBESITY; PATIENT DECISION MAKING; PREGNANCY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; SAFETY; SMOKING; THROMBOEMBOLISM; TRANSDERMAL PATCH; VAGINA RING; VENOUS THROMBOEMBOLISM;

EID: 80053354633     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.06.057     Document Type: Review

References (36)

1. Hormonal contraception: recent advances and controversies Fertil Steril 90 Suppl 2008 S103 S113
2. P.D. Blumenthal, and A. Edelman Hormonal contraception Obstet Gynecol 112 2008 670 684
3. P.C. Hannaford, S. Selvaraj, A.M. Elliott, V. Angus, L. Iversen, and A.J. Lee Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study BMJ 335 2007 651
4. A.J. Rapkin YAZ in the treatment of premenstrual dysphoric disorder J Reprod Med 53 Suppl 2008 729 741
5. J.T. Jensen Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest Expert Opin Pharmacother 11 2010 1147 1157
6. D. Grossman, L. Fernandez, K. Hopkins, J. Amastae, and J.E. Potter Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas Contraception 81 2010 254 260
7. S. Pariani, D.M. Heer, and M.D. Van Arsdol Jr Does choice make a difference to contraceptive use? Evidence from east Java Stud Fam Plann 22 1991 384 390
8. NuvaRing [package insert] 2008 Organon USA Inc Roseland, NJ
9. Ortho Evra [package insert] 2010 Ortho-McNeil-Janssen Pharmaceuticals, Inc Raritan, NJ
10. R.I. Bjarnadottir, M. Tuppurainen, and S.R. Killick Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ ethinyl estradiol Am J Obstet Gynecol 186 2002 389 395 (Pubitemid 34234146)
11. C.J. Timmer, and T.M. Mulders Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring Clin Pharmacokinet 39 2000 233 242
12. T.O. Dieben, F.J. Roumen, and D. Apter Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring Obstet Gynecol 100 2002 585 593 (Pubitemid 35246150)
13. Ortho Evra [package insert] 2010 ORTHO Women's Health & Urology, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc Raritan, NJ
14. M. Zieman, J. Guillebaud, E. Weisberg, G.A. Shangold, A.C. Fisher, and G.W. Creasy Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data Fertil Steril 77 Suppl 2 2002 S13 S18
15. D.F. Archer, A. Bigrigg, G.H. Smallwood, G.A. Shangold, G.W. Creasy, and A.C. Fisher Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women Fertil Steril 77 Suppl 2 2002 S27 S31
16. M.W. van den Heuvel, A.J. van Bragt, A.K. Alnabawy, and M.C. Kaptein Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive Contraception 72 2005 168 174 (Pubitemid 41133355)
17. S.S. Jick, J.A. Kaye, S. Russmann, and H. Jick Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol Contraception 73 2006 223 228 (Pubitemid 43202170)
18. J.A. Cole, H. Norman, M. Doherty, and A.M. Walker Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users Obstet Gynecol 109 Pt 1 2007 339 346 (Pubitemid 46197426)
19. S.S. Jick, K.W. Hagberg, R.K. Hernandez, and J.A. Kaye Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism Contraception 81 2010 16 21
20. R. Hatcher, J. Trussell, A. Nelson, W. Cates Jr, F. Stewart, and D. Kowal Contraceptive technology 19th ed. 2008 Ardent Media Inc New York, NY
21. M.J. Rosenberg, and M.S. Waugh Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons Am J Obstet Gynecol 179 Pt 1 1998 577 582 (Pubitemid 28447229)
22. W. Oelkers Drospirenone, a progestogen with antimineralocorticoid properties: a short review Mol Cell Endocrinol 217 2004 255 261 (Pubitemid 38596651)
23. Yasmin [package insert] 2010 Bayer HealthCare Pharmaceuticals Inc Wayne, NJ
24. Yaz [package insert] 2010 Bayer HealthCare Pharmaceuticals Inc Wayne, NJ
25. J.C. Dinger, L.A. Heinemann, and D. Kuhl-Habich The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation Contraception 75 2007 344 354 (Pubitemid 46551071)
26. J.D. Seeger, J. Loughlin, P.M. Eng, C.R. Clifford, J. Cutone, and A.M. Walker Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives Obstet Gynecol 110 2007 587 593 (Pubitemid 47359582)
27. O. Lidegaard, E. Lokkegaard, A.L. Svendsen, and C. Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 2009 b2890
28. A. van Hylckama Vlieg, F.M. Helmerhorst, J.P. Vandenbroucke, C.J. Doggen, and F.R. Rosendaal The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study BMJ 339 2009 b2921
29. H. Sullivan, H. Furniss, J. Spona, and M. Elstein Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity Fertil Steril 72 1999 115 120 (Pubitemid 29300271)
30. P.J. Sulak, R.D. Scow, C. Preece, M.W. Riggs, and T.J. Kuehl Hormone withdrawal symptoms in oral contraceptive users Obstet Gynecol 95 2000 261 266 (Pubitemid 30045651)
31. D.R. Mishell Jr. Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations Contraception 71 2005 304 305 (Pubitemid 40416720)
32. J. Spona, M. Elstein, and W. Feichtinger Shorter pill-free interval in combined oral contraceptives decreases follicular development Contraception 54 1996 71 77 (Pubitemid 26256707)
33. A. Poindexter The emerging use of the 20-microg oral contraceptive Fertil Steril 75 2001 457 465 (Pubitemid 32177776)
34. H.J. Ahrendt, D. Makalova, S. Parke, U. Mellinger, and D. Mansour Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel Contraception 80 2009 436 444
35. J. Endrikat, S. Parke, D. Trummer, W. Schmidt, I. Duijkers, and C. Klipping Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies Contraception 78 2008 218 225
36. I.J. Duijkers, C. Klipping, P. Grob, and T. Korver Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol Eur J Contracept Reprod Health Care 15 2010 314 325